Pliant Therapeutics Inc (PLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -42,800 | -29,545 | -14,023 | -30,276 |
| Depreciation Amortization | 823 | 536 | 256 | 666 |
| Accounts payable and accrued liabilities | 212 | 1,815 | 1,768 | N/A |
| Other Working Capital | 1,185 | 3,573 | 2,608 | 1,054 |
| Other Operating Activity | 1,086 | -997 | -1,456 | 228 |
| Operating Cash Flow | $-39,494 | $-24,618 | $-10,847 | $-28,328 |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | -7,970 | -21,765 | -27,159 | N/A |
| PPE Investments | -780 | -732 | -258 | -2,323 |
| Investing Cash Flow | $-8,750 | $-22,497 | $-27,417 | $-2,323 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 146 | 132 | N/A | N/A |
| Other Financing Activity | -1,438 | -1,030 | -127 | 87,349 |
| Financing Cash Flow | $-1,292 | $-898 | $-127 | $87,349 |
| Beginning Cash Position | 60,949 | 60,949 | 60,949 | 4,251 |
| End Cash Position | 11,413 | 12,936 | 22,558 | 60,949 |
| Net Cash Flow | $-49,536 | $-48,013 | $-38,391 | $56,698 |
| Free Cash Flow | ||||
| Operating Cash Flow | -39,494 | -24,618 | -10,847 | -28,328 |
| Capital Expenditure | -780 | -732 | -258 | N/A |
| Free Cash Flow | -40,274 | -25,350 | -11,105 | -28,328 |